Eczema in Children:
Management Strategies That Work

Atopic dermatitis (eczema) affects approximately 1 in 10 children in the United States. It is characterized by a chronic itch-scratch cycle that disrupts sleep, affects concentration, and significantly impacts quality of life for both children and parents. With a structured management approach — consistent moisturization, trigger identification, and appropriate topical therapy — the frequency and severity of flares can be dramatically reduced.

Understanding Eczema: What Is Actually Happening in the Skin

Atopic dermatitis is not simply dry skin. It is an immune-mediated inflammatory condition rooted in a dysfunctional skin barrier. Most patients with eczema have mutations in the filaggrin gene — the protein that holds skin cells together and maintains the barrier. When filaggrin is deficient, the skin barrier is "leaky": water escapes (transepidermal water loss), and allergens, irritants, and microorganisms penetrate the skin and trigger an immune response.

This explains why eczema is often associated with food allergies, asthma, and hay fever — the "atopic march" — and why simple moisturization (repairing the barrier) is genuinely therapeutic, not just cosmetic.

The Core Management Framework

1. Consistent moisturization (the non-negotiable foundation)

   Apply a thick fragrance-free emollient cream or ointment (petroleum jelly, CeraVe Cream, Aquaphor, Vanicream) within 3 minutes of bathing while skin is still damp — the "soak and smear" technique. Aim for twice-daily application year-round, even during remission. Lotions are insufficient.

2. Gentle bathing routine

   Lukewarm (never hot) baths or showers of 5–10 minutes daily using a fragrance-free, non-soap cleanser (Dove Sensitive, CeraVe, Vanicream). Pat — do not rub — dry with a soft towel. Avoid bubble baths, scented soaps, and harsh scrubbing.

3. Identify and reduce environmental triggers

   Common triggers include dust mites, pet dander, mold, pollen, synthetic fabrics (polyester, wool), fragrance (laundry detergent, dryer sheets, soaps), cigarette smoke, and sweat. Washing bedding in hot water weekly, using mattress/pillow covers, and dressing children in 100% cotton can reduce exposure significantly.

4. Appropriate topical therapy for active flares

   Low- to mid-potency topical corticosteroids (hydrocortisone 1–2.5% for the face/folds; triamcinolone or stronger for the body) applied once or twice daily until the flare resolves — then tapered. Non-steroidal topical calcineurin inhibitors (tacrolimus, pimecrolimus) are a useful alternative for sensitive areas. Topical PDE4 inhibitors (crisaborole) and JAK inhibitors (ruxolitinib) are newer options for mild-to-moderate eczema.

5. Proactive ("weekend") therapy for recurrence-prone areas

   For children who flare repeatedly in the same body sites (elbow creases, behind knees, wrists), applying a low-potency topical steroid 2 days per week to those areas — even when clear — significantly reduces flare frequency. This is supported by strong clinical evidence and is safe when used as directed.

Food Allergies and Eczema

The relationship between food allergy and eczema is often misunderstood. Eliminating foods is rarely the primary treatment for eczema — and aggressive food elimination in young children carries its own risks (nutritional deficiency, development of food aversion). Food allergy evaluation is most appropriate when:

• Eczema is severe and not responding to standard topical treatment
• There is a clear and reproducible pattern of worsening after specific food exposure
• Other atopic conditions (hives, GI symptoms) are present

When to Escalate: Systemic Therapy

For children with moderate-to-severe eczema not controlled by optimized topical therapy, systemic options are available and have transformed outcomes in recent years:

• Dupilumab (Dupixent®) — a biologic (anti-IL-4/IL-13 antibody) approved for children aged 6 months and older with moderate-to-severe atopic dermatitis. Highly effective with an excellent safety profile. Given as a biweekly subcutaneous injection.
• Oral JAK inhibitors (abrocitinib, upadacitinib) — approved for adolescents 12+ with moderate-to-severe atopic dermatitis. Rapid onset, given orally daily.
• Wet wrap therapy — intensive topical technique using moistened inner dressings over topical steroids, covered by dry outer wraps; appropriate for severe acute flares under physician supervision.

Eczema is one of the most common conditions managed by Belaray's pediatric dermatology team, which cares for children's skin from infancy through the teenage years. Other chronic inflammatory skin conditions — including psoriasis — are treated with the same structured, evidence-based approach.

Frequently Asked Questions